Menu Search
Equities

Icecure Medical Ltd

ICCM:NAQ

Icecure Medical Ltd

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.64
  • Today's Change-0.01 / -1.54%
  • Shares traded140.74k
  • 1 Year change+11.30%
  • Beta2.6576
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Icecure Medical Ltd grew revenues 4.67% from 3.09m to 3.23m while net income improved from a loss of 16.98m to a smaller loss of 14.65m.
Gross margin40.32%
Net profit margin-410.22%
Operating margin-432.13%
Return on assets-71.93%
Return on equity-94.22%
Return on investment-92.10%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Icecure Medical Ltd fell by 13.13m. Cash Flow from Financing totalled 83.00k or 2.57% of revenues. In addition the company used 12.52m for operations while cash used for investing totalled 713.00k.
Cash flow per share-0.2856
Price/Cash flow per share--
Book value per share0.2143
Tangible book value per share0.2143
More ▼

Balance sheet in USDView more

Icecure Medical Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio2.97
Quick ratio2.54
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.